EDGAR Filing Documents for 0001104659-23-046286

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001104659-23-046286

Filing Date

2023-04-17

Accepted

2023-04-17 17:11:08

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	tm2312583-1_s3.htm	S-3	462588
2	EXHIBIT 4.3	tm23125832_ex4-3.htm	EX-4.3	369072
3	EXHIBIT 4.4	tm23125832_ex4-4.htm	EX-4.4	394552
4	EXHIBIT 4.5	tm23125832_ex4-5.htm	EX-4.5	41956
5	EXHIBIT 4.6	tm23125832_ex4-6.htm	EX-4.6	42090
6	EXHIBIT 5.1	tm23125832_ex5-1.htm	EX-5.1	38956
7	EXHIBIT 23.1	tm23125832_ex23-1.htm	EX-23.1	2850
8	EXHIBIT 23.2	tm23125832_ex23-2.htm	EX-23.2	3066
9	EX-FILING FEES	tm23125832_ex-filingfees.htm	EX-FILING FEES	54024
10	GRAPHIC	lg_carismatherapeutics-4c.jpg	GRAPHIC	93019
11	GRAPHIC	tm23125832_ex5-1img001.jpg	GRAPHIC	1646
12	GRAPHIC	tm23125832_ex5-1img002.jpg	GRAPHIC	6447
	Complete submission text file	0001104659-23-046286.txt		1550052

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104

Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422

Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)